Shenzhen Maiwei Medical Technology Co., Ltd. (established in May 2024) is a subsidiary of Shenzhen Maiwei Biotechnology Co., Ltd. (established in March 2016), headquartered in Shenzhen, Guangdong. Maiwei's core business focuses on the medical imaging field, specializing in the research, development, production, and sales of high-pressure contrast injection systems and consumables. It is a significant breakthrough player in high-end high-pressure contrast injection system consumables and equipment in China. Maiwei Medical has successfully developed a full range of high-pressure injector systems, including syringe-type CT high-pressure injectors, system-line CT high-pressure injectors, syringe-type MR high-pressure injectors, system-line MR high-pressure injectors, and DSA high-pressure injectors, covering mainstream medical imaging scenarios, with technical specifications benchmarked against international advanced levels.